Ebola vaccine developed in Canada shows promising results
Monday, June 19, 2017 - 11:22
in Health & Medicine
A phase 1 randomized controlled trial has found an Ebola virus disease vaccine was well-tolerated with no safety concerns, and high antibodies were present in participants six months after immunization.